Hasil Pencarian (2)
small molecule | CAS: 2097132-94-8
Pralsetinib, similar to the previously approved [selpercatinib], is a kinase inhibitor with enhanced specificity for RET tyrosine kinase receptors (RTKs) over other RTK classes.[A202055, A219751, L15986] Enhanced RET (Rearranged during transfection) oncogene …
Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 Inhibitors
+38
Target Protein:
Proto-oncogene tyrosine-protein kinase receptor RetEpithelial discoidin domain-containing receptor 1NT-3 growth factor receptor
+8
Waktu ParuhPralsetinib has a p…
Vol. DistribusiPralsetinib has a m…
KlirensPralsetinib has a m…
Genetik
-
small molecule | CAS: 2152628-33-4
Selpercatinib is a kinase inhibitor with enhanced specificity for RET tyrosine kinase receptors (RTKs) over other RTK classes.[A202055, A202052, L13604] Enhanced RET (Rearranged during transfection) oncogene expression is a hallmark of many cancers. Although …
Kategori:
Agents that produce hypertensionAntineoplastic AgentsAntineoplastic and Immunomodulating Agents
+19
Target Protein:
Proto-oncogene tyrosine-protein kinase receptor RetVascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 3
+3
Waktu ParuhSelpercatinib has a…
Vol. DistribusiSelpercatinib has a…
KlirensSelpercatinib has a…
Genetik
-